ℹ️
🇬🇧
Search
Search for people relevant for ""
Class
Person
Publication
Programmes
Giovanni Scambia
Person without affiliation with CUNI
1 publication
Publication
publication
Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial
2022 |
First Faculty of Medicine
Loading network view...